Ongoing monitoring and treatment of RA patients’ mental health is important and may impact long-term RA outcomes.

A randomized-control trial found that mind-body skills training improved depressive symptoms in patients with SLE.

Recognizing depression in PsA is important because psychological well-being may contribute to disease activity in PsA.

Levels of depression and anxiety varied by disease. Special attention should be paid to patients with fibromyalgia, osteoarthritis, and rheumatoid arthritis.

Secukinumab treatment was associated with higher ASAS 20 response rates at weeks 16, 24, and 52 and ASAS 40 at weeks 24 and 52 compared with treatment with adalimumab.

High cytomegalovirus titer is associated with mortality in patients with rheumatic disease.

Serious adverse events that require hospitalization significantly impact stroke risk in patients with rheumatoid arthritis.

Biologic originator to biosimilar switching is recommended to remain a clinical decision made by the treating physician and patient

Hydroxychloroquine use was associated with a duration-dependent reduction in risk of developing diabetes.

Nearly half of patients with septic arthritis with poor functional outcome who underwent ultrasonography (US) showed decreased synovial thickness at 3 months compared to baseline.

By 2030, excess demand expected to be 138% more than supply, versus 36% currently

Allopurinol use was found to be associated with a reduced risk of ischemic stroke.

Patients with clinically suspect arthralgia who have circulating anti-citrullinated protein antibodies (ACPAs) and rheumatoid factor (RF) are at an increased risk of clinical arthritis progression, according to research presented at the American College of Rheumatology 2016 annual meeting. Robin M ten Brinck, PhD candidate from the Department of Rheumatology at Leiden University Medical Center, the…

Most commonly used to treat chronic uveitis, weekly adalimumab was linked to a positive clinical response in 93% of patients.

Patients with hand osteoarthritis can benefit from non-pharmacological treatment in a structured arthritis rehabilitation program.

WASHINGTON, DC — Researchers evaluating the 3-year efficacy of secukinumab found that it safe and efficacious in the treatment of psoriatic arthritis (PsA) across multiple dosages, according to recent research recently presented at the American College of Rheumatology 2016 annual meeting. Philip J Mease, MD, from the Swedish Medical Center and University of Washington, Seattle,…

WASHINGTON, DC — Treatment of psoriatic arthritis (PsA) with ixekizumab (IXE)—an IgG4 monoclonal antibody—significantly improves arthritis, dactylitis and enthesitis at 52-weeks, according to research presented at the 2016 American College of Rheumatology Annual Meeting. Philip J Mease, MD, at the Swedish Medical Center and the University of Washington, and colleagues conducted a phase 3 study…

Adalimumab therapy added to initial methotrexate (MTX) therapy in patients with early RA and history of inadequate response to MTX results in a reduction in disease activity and halts further radiographic progression.

Cycling to a different tumor necrosis factor alpha inhibitor after initial treatment failure should be considered in patients with rheumatoid arthritis

WASHINGTON, DC — There was no change in safety profile for adalimumab in pediatric patients with polyarticular juvenile idiopathic arthritis (pJIA), enthesitis-related arthritis (ERA), psoriasis (Ps), and Crohn’s disease (CD), a recent analysis showed. The research was presented at the American College of Rheumatology (ACR) 2016 Annual Meeting. Gerd Horneff, MD, from the Asklepios Kliniken GmbH…

WASHINGTON, DC — While it is established that interstitial lung disease (ILD) is linked with higher morbidity in patients with rheumatoid arthritis (RA), insights into the long-term progression of pulmonary impairment in such patients are lacking. Findings to be presented at the 2016 annual meeting of the American College of Rheumatology (ACR) will offer some initial…